Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-07
-
Redefining DPP-4 Inhibition: Translational Strategy with Sit
2026-06-03
This article empowers translational researchers with a mechanistic deep dive into DPP-4 inhibition, showcasing how Sitagliptin phosphate monohydrate from APExBIO advances the frontier of type II diabetes research. Integrating new evidence on incretin modulation and gastrointestinal stretch signaling, we translate molecular insight into practical guidance for designing robust experiments and interpreting outcomes in metabolic disease models.
-
Streptozotocin in Diabetes Research: Protocols & Innovations
2026-06-03
Streptozotocin (STZ) remains the gold standard for inducing experimental diabetes via targeted pancreatic β-cell cytotoxicity. This article dives into advanced protocols, troubleshooting, and the latest mechanistic insights—empowering researchers with optimized workflows and translational strategies.
-
Q-VD(OMe)-OPh: Precision Pan-Caspase Inhibition in Apoptosis
2026-06-02
Q-VD(OMe)-OPh, a potent quinolyl-valyl-O-methylaspartyl-[-2,6-difluorophenoxy]-methyl ketone, is a benchmark broad-spectrum pan-caspase inhibitor. It offers high specificity and low cytotoxicity, enabling precise apoptosis modulation for cancer, neuroprotection, and differentiation studies.
-
InstaBlue Protein Stain Solution: Rapid Coomassie Staining i
2026-06-02
InstaBlue Protein Stain Solution provides researchers with a fast, ready-to-use method for visualizing proteins in polyacrylamide gels, eliminating the need for fixation, washing, or destaining. It is best suited for workflows requiring quick, sensitive detection and mass spectrometry compatibility, but is not intended for applications needing post-staining modifications or for use with non-polyacrylamide matrices.
-
TPPU: Advanced Soluble Epoxide Hydrolase Inhibitor Protocols
2026-06-01
TPPU is reshaping experimental workflows in inflammation, pain, and bone metabolism research as a potent, selective soluble epoxide hydrolase inhibitor. This article guides researchers through optimized assay protocols, troubleshooting strategies, and novel mechanistic insights, including the hepatic sEH–Nrf2–osteoclastogenesis axis. Discover how TPPU from APExBIO delivers reproducibility and translational relevance across preclinical models.
-
RIPA Lysis Buffer (Strong): Precision Protein Extraction for
2026-06-01
Explore advanced strategies for protein extraction using RIPA Lysis Buffer (Strong) in neuroimmune studies. Learn how this robust buffer empowers high-integrity sample preparation for assays investigating macrophage–neuron interactions and beyond.
-
EZ Cap Cy5 Firefly Luciferase mRNA: Breakthrough Dual-Mode T
2026-05-31
EZ Cap Cy5 Firefly Luciferase mRNA (5-moUTP) redefines precision in mRNA delivery and intracellular tracking. Its dual-mode fluorescence-bioluminescence design enables seamless quantitation, troubleshooting, and optimization in advanced gene transfer and vaccine studies.
-
Comparative Cardiovascular Outcomes of SGLT2 Inhibitors in T
2026-05-30
This systematic review and network meta-analysis rigorously compared the cardiovascular benefits and safety profiles of five individual SGLT2 inhibitors, including Ertugliflozin (PF-04971729), in patients with type 2 diabetes (T2D) and heart failure (HF). The findings clarify the relative efficacy of these agents for reducing heart failure hospitalization and composite cardiovascular events, guiding research and clinical priorities in diabetic cardiometabolic care.
-
Amiloride (MK-870): Translational Leverage in Sodium Channel
2026-05-29
Explore the mechanistic underpinnings and translational strategies for using Amiloride (MK-870) in sodium channel and endocytosis research. This thought-leadership article integrates recent evidence, practical workflow guidance, and a forward-looking vision for its impact across disease models, positioning APExBIO’s reagent as a cornerstone for next-generation studies.
-
Dual Luciferase Reporter Gene System: Advancing lncRNA Resea
2026-05-29
Explore how the Dual Luciferase Reporter Gene System enables precise gene expression regulation studies, with a special focus on lncRNA-mediated pathways. Discover unique insights into assay selection informed by recent breakthroughs in stem cell biology.
-
Cy5 TSA Fluorescence System Kit: Precision Signal Amplificat
2026-05-28
The Cy5 TSA Fluorescence System Kit transforms immunochemistry by enabling ultra-sensitive, high-resolution detection of low-abundance targets. Its robust, HRP-catalyzed tyramide deposition workflow empowers researchers to capture spatially-resolved cellular events with confidence—even in challenging tissue contexts.
-
Cefepime (BMY-28142) in CNS Infection Models: Protocols & In
2026-05-28
Cefepime (BMY-28142) stands out for its robust, broad-spectrum antimicrobial activity and unique blood-brain barrier penetration, enabling advanced research into central nervous system infections and resistance mechanisms. This guide translates recent resistance modeling breakthroughs into actionable protocols, troubleshooting, and workflow enhancements for maximizing research impact.
-
NADH in Applied Research: Protocols and Pitfalls in Redox Mo
2026-05-27
Unlock the full potential of NADH (Reduced-form Nicotinamide Adenine Dinucleotide) in modeling mitochondrial dysfunction and redox imbalance. This guide delivers actionable protocols, troubleshooting strategies, and advanced workflows—directly informed by landmark DKD research and peer-reviewed assay innovations.
-
Abiraterone Acetate: Enhancing CYP17 Inhibitor Workflows in
2026-05-27
Harnessing Abiraterone acetate as a potent CYP17 inhibitor transforms prostate cancer research by enabling precise androgen pathway modulation in advanced 3D culture models. This guide delivers protocol strategies, troubleshooting insights, and evidence-led innovations for translational and preclinical studies.
-
Dual Luciferase Reporter Gene System: Sensitive Gene Regulat
2026-05-26
The Dual Luciferase Reporter Gene System enables highly sensitive, normalized quantification of gene expression regulation in mammalian cells. By leveraging firefly and Renilla luciferase substrates, the K1136 kit from APExBIO facilitates robust bioluminescence reporter assays for transcriptional regulation studies. Its direct-addition workflow supports reproducible, high-throughput luciferase detection and accurate normalization.